PASADENA, Calif. (AP) 鈥� PASADENA, Calif. (AP) 鈥� Xencor Inc. (XNCR) on Wednesday reported a loss of $21.7 million in its second quarter.
On a per-share basis, the Pasadena, California-based company said it had a loss of 29 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 82 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $51.2 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $11.7 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/XNCR
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
